<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04899726</url>
  </required_header>
  <id_info>
    <org_study_id>P201630551</org_study_id>
    <nct_id>NCT04899726</nct_id>
  </id_info>
  <brief_title>Description of the Safety and Functionality of a Rectoscope (P201630551)</brief_title>
  <official_title>Description of the Safety and Functionality of a Rectoscope (P201630551) That Allows the Identification of the Distal Section Margin in Oncological Rectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Investigación Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Investigación Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Most patients with rectal cancer receive neoadjuvant therapy. This usually causes a decrease&#xD;
      in tumor size. In approximately 20% of patients who receive neoadjuvant therapy, the tumor&#xD;
      disappears completely (complete pathological response), showing as a scar on the rectal&#xD;
      mucosa, not noticeable from the rectal serosa, from outside the rectum, difficulting the&#xD;
      identification of the tumor location by the surgeon.&#xD;
&#xD;
      Rectoscope (p201630551) allows the surgeon to view the illuminated rectum from the patient's&#xD;
      abdomen, determining the appropriate point of section of the rectum.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 14, 2020</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Pilot Study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of adverse events related to use of the device.</measure>
    <time_frame>at immediate postoperative period</time_frame>
    <description>Safety. Clavien-Dindo classification will be used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of functionality</measure>
    <time_frame>at surgery</time_frame>
    <description>Categorical variable. 3 options:&#xD;
the device has worked without problems&#xD;
the device has worked, but with problems&#xD;
the device could not carry out its function.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Oncological Rectal Surgery</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oncology patients candidate for rectal surgery (tumors located up to 15 cm from the anal margin) and meet inclusion criteria. Rectoscope (P201630551) allows the identification of the distal section margin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rectoscope (P201630551)</intervention_name>
    <description>Rectoscope (P201630551) allows the identification of the distal section margin in oncological rectal surgery.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women over 18 years old.&#xD;
&#xD;
          -  Patients with rectal cancer (15 cm or less from the anal margin), whether or not they&#xD;
             have received neoadjuvant treatment, in whom cancer surgery is to be performed through&#xD;
             the anterior (abdominal) route, whether laparoscopic or not.&#xD;
&#xD;
          -  Patients who accept their participation in this study, after explaining the study&#xD;
             details.&#xD;
&#xD;
          -  Patients who sign the informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are going to undergo an abdominoperineal amputation or transanal surgery&#xD;
             for rectal cancer.&#xD;
&#xD;
          -  Patients who do not accept their participation in this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario Álvarez Gallego, MD</last_name>
      <phone>914975485</phone>
      <email>mario.alvarez@salud.madrid.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 21, 2021</study_first_submitted>
  <study_first_submitted_qc>May 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2021</study_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

